-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Arrowhead Pharma, Raises Price Target to $100

Benzinga·01/21/2026 15:09:47
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and raises the price target from $85 to $100.